The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?| Labiotech.eu
As the biotech industry flourishes, drug developers need to interact increasingly with patient organizations, especially in the rare disease space.| Labiotech.eu
Unlock exclusive career opportunities in biotech and biopharma with our curated list of top life sciences job boards.| Labiotech.eu
Biotech startups are a high-risk venture. Experts explain what the most common reasons for failure are and what can be done to avoid them.| Labiotech.eu
Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.| Labiotech.eu
Mission statement, purpose and vision are essential to the success of a biotech. Delve into the stategies to build on company culture.| Labiotech.eu
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]| Labiotech.eu
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What's the reason for this funding peak?| Labiotech.eu
Since the Hormone Replacement Therapy market was destroyed almost overnight in 2002, there has been a lot of caution about investing in companies with a focus on women’s health. Mary Kerr, CEO of KaNDy Therapeutics and NeRRe Therapeutics, knows this only too well, but has not let it deter her in her quest to bring a treatment for symptoms of the menopause to the market.| Labiotech.eu
Many biotech entrepreneurs dread the possibility of investors taking control in a situation that resembles a hostile takeover. But it needn't be that way.| Labiotech.eu
Building a biotech startup can be a daunting task and often founders rely on incubators - but how to choose the right one?| Labiotech.eu
Sabine Dandiguian, Managing Partner at the life sciences VC firm Jeito Capital, shares her experience building a thriving company culture.| Labiotech.eu
What's my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face.| Labiotech.eu
To honor International Women's Day, we asked female biotech leaders for their tips on how to encourage women in the life sciences industry.| Labiotech.eu
Hiring is a big challenge in biotech; life sciences recruitment experts share their strategies for attracting and retaining talent in the biotech industry.| Labiotech.eu
As new measures are being developed to spur quicker and efficient diagnoses, here are six molecular diagnostics companies to look out for.| Labiotech.eu
Here is a list of 14 biotech podcasts to keep you up to date with the latest advances in the biotechnology industry.| Labiotech.eu
To commemorate Lupus Awareness Month in May, here are five advancements in lupus research over the past year.| Labiotech.eu
As we celebrate International Women’s Day, here are 5 women who are leading the way in research and innovation in the biotech industry!| Labiotech.eu
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer.| Labiotech.eu
The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.| Labiotech.eu
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.| Labiotech.eu
The companies Uniquity Bio, AltruBio, and BridgeBio Oncology Therapeutics bagged the biggest private biotech investments in May 2024.| Labiotech.eu
The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024.| Labiotech.eu
The companies Xaira Therapeutics, Metsera, and Obsidian Therapeutics bagged the biggest private biotech investments in April 2024.| Labiotech.eu
Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped capital.| Labiotech.eu
Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall in July 2025.| Labiotech.eu
New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far along are they?| Labiotech.eu
Discover Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution!| Labiotech.eu
Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce risk.| Labiotech.eu
NATO Innovation Fund backs Portal Biotech in its first biotech move. What does this signal for strategic investment in healthcare innovation?| Labiotech.eu
XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.| Labiotech.eu
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.| Labiotech.eu
Australia's bet is to keep its biotech landscape innovative throught R&D tax incentives. Delve into their strategy and its results.| Labiotech.eu
Read more to find out what role ChatGPT has to play in the drug discovery process within the life sciences industry.| Labiotech.eu
A spate of royalty deals are changing the way certain biotechs press ahead, as seen with Cytokinetics’ agreement with Royalty Pharma.| Labiotech.eu
Plastic is the staple material of modern life, and a sustainable future will need bioplastics. What is Biotech doing to make this happen?| Labiotech.eu
Find out how CAR-T cell therapy, which has been so groundbreaking in treating blood cancers, could potentially cure glioblastoma.| Labiotech.eu
Discover expert advice from recruiters on crafting a standout biotech resume that grabs employers' attention and lands you interviews.| Labiotech.eu
Check out five important biotechnology careers that are currently in high demand, and likely still will be in the coming years.| Labiotech.eu
Building a career in biotech can be a daunting task without the right skills. Delve into the strategies to improve and leverage them.| Labiotech.eu
Alan Levy shares his experience on how to make the relationship between the board and the CEO of a life sciences company work.| Labiotech.eu
Here is a list of ten recruiters in the biotech space, nominated by our readers, who are making strides in the life science sector.| Labiotech.eu
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.| Labiotech.eu
The companies Cardurion Pharmaceuticals, Beacon Therapeutics, and Third Arc Bio bagged the biggest private biotech investments in July 2024.| Labiotech.eu
The companies Borealis Biosciences, Outpace Bio, and Halda Therapeutics bagged the biggest private biotech investments in August 2024.| Labiotech.eu
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.| Labiotech.eu
The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in development.| Labiotech.eu
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.| Labiotech.eu
GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.| Labiotech.eu
The emerging spatial transcriptomics field is letting researchers map out gene expression in tumor and brain samples. How could this change the way we treat disease?| Labiotech.eu
In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines.| Labiotech.eu
Uncover the promise of KRAS inhibitors in cancer treatment, as evidenced by a $200 million investment in BridgeBio's spinout.| Labiotech.eu
The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024.| Labiotech.eu
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.| Labiotech.eu
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.| Labiotech.eu
Discover our top biotech job tips, as we list five things you could do to increase your chances of securing your dream job in the industry.| Labiotech.eu
The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.| Labiotech.eu
Discover how GLP-1 agonists, known for treating diabetes and obesity, are now being studied for their potential in tackling heart diseases.| Labiotech.eu